{"id":229104,"date":"2024-08-08T15:29:51","date_gmt":"2024-08-08T15:29:51","guid":{"rendered":"https:\/\/bm.dev.synology.me\/?p=229104"},"modified":"2024-08-08T15:29:51","modified_gmt":"2024-08-08T15:29:51","slug":"leacul-pentru-vindecarea-cancerului-e-mai-aproape-ca-niciodata-o-mana-de-companii-sunt-aproape-sa-gaseasca-solutia-la-unul-dintre-cele-mai-complicate-puzzleuri-ale-stiintei","status":"publish","type":"post","link":"https:\/\/bm.dev.synology.me\/?p=229104","title":{"rendered":"Leacul pentru vindecarea cancerului e mai aproape ca niciodat\u0103. O m\u00e2n\u0103 de companii sunt aproape s\u0103 g\u0103seasc\u0103 solu\u0163ia la unul dintre cele mai complicate puzzleuri ale \u015ftiin\u0163ei"},"content":{"rendered":"<p>\nEli Lilly, cel mai mare grup pharma din lume, intr\u0103 \u00een afacerile cu izotopi nucleari, pentru a-\u015fi asigura materialele esen\u0163iale unui nou tratament \u00eempotriva cancerului. Compania a investit 10 mil. dolari \u00een Ionetix, un furnizor de izotopi nucleari, care este capabil s\u0103 produc\u0103 actiniu-225, cea mai important\u0103 resurs\u0103 \u00een domeniul tratamentelor oncologice radiofarmaceutice, scrie Financial Times.<\/p>\n<p>\nProdusele radiofarmaceutice, cunoscute \u015fi sub denumirea de radioliganzi, reprezint\u0103 unul dintre cele mai promi\u0163\u0103toare domenii noi de tratament al cancerului, \u00een care, prin combinarea unui izotop radioactiv cu un cocktail de anticorpi, produc\u0103torii de medicamente pot furniza o doz\u0103 mai toxic\u0103 direct celulelor canceroase, mic\u015for\u00e2nd tumorile \u00een mod eficient.<\/p>\n<p>\n\u00cen 2023, Eli Lilly a cump\u0103rat Point Biopharma, o companie biotehnologic\u0103 specializat\u0103 \u00een medicamente radiofarmaceutice pentru tratarea cancerului de prostat\u0103, pentru 1,4 miliarde de dolari.<\/p>\n<p>\n&nbsp;Grupurile farmaceutice Bayer \u015fi Novartis au aprobat deja medicamente radiofarmaceutice care utilizeaz\u0103 diferi\u0163i izotopi.<\/p>\n<p>\n.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Eli Lilly, cel mai mare grup pharma din lume, intr\u0103 \u00een afacerile cu izotopi nucleari, pentru a-\u015fi asigura materialele esen\u0163iale unui nou tratament \u00eempotriva cancerului. Compania a investit 10 mil. dolari \u00een Ionetix, un furnizor de izotopi nucleari, care este capabil s\u0103 produc\u0103 actiniu-225, cea mai important\u0103 resurs\u0103 \u00een domeniul tratamentelor oncologice radiofarmaceutice, scrie Financial [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[14610,246,8088,9823,7676,12923],"class_list":["post-229104","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-cancer","tag-crestere","tag-farma","tag-furnizor","tag-nuclear","tag-tratament"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/229104","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=229104"}],"version-history":[{"count":0,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/229104\/revisions"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=229104"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=229104"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=229104"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}